Although nanocatalytic
therapy has become an emerging strategy for
tumor treatment, the
therapeutic effects of
reactive oxygen species (ROS)-mediated treatment are still seriously limited by the inherent flaws of the enzymatic activities and the specific physicochemical properties of the tumor microenvironment (TME). Herein, we report an ultrasmall bimetallic
oxide nanozyme (
CuFe2O4@PEG, CFOs) for programmable multienzyme-like activities-primed combined
therapy. Under the acidic condition, abundant highly toxic ROS can be generated through the
peroxidase activity of CFOs with overexpressed
hydrogen peroxide (H2O2) in the
tumor. High
metal ion utilization of bimetallic
oxide nanozymes is related to the size effect and topological structure. Furthermore,
glutathione peroxidase activity-initiated depletion of GSH disrupts the intracellular
antioxidant defense system and further amplifies the oxidative stress in turn. Subsequently,
oxygen generation originating from the
catalase activity of CFOs relieves tumor hypoxia and achieves exceptional TME-customized
therapeutic effects. Notably, the high photothermal effect (η = 41.12%) of CFOs in the second near-infrared biological windows leads to the combinational inhibition of
tumor growth. In summary, this report provides a paradigm for the rational design of TME-responsive and ROS-mediated nanocatalytic treatment, which is promising for achieving superior therapeutic efficiency.